| Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays MJ Kozal, N Shah, N Shen, R Yang, R Fucini, TC Merigan, DD Richman, ... Nature medicine 2 (7), 753-759, 1996 | 906 | 1996 |
| Using oligonucleotide probe arrays to access genetic diversity. RJ Lipshutz, D Morris, M Chee, E Hubbell, MJ Kozal, N Shah, N Shen, ... Biotechniques 19 (3), 442-447, 1995 | 726 | 1995 |
| Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment–naive patients significantly impact treatment outcomes BB Simen, JF Simons, KH Hullsiek, RM Novak, RD MacArthur, JD Baxter, ... The Journal of infectious diseases 199 (5), 693-701, 2009 | 469 | 2009 |
| Dolutegravir in antiretroviral-experienced patients with raltegravir-and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study A Castagna, F Maggiolo, G Penco, D Wright, A Mills, R Grossberg, ... The Journal of infectious diseases 210 (3), 354-362, 2014 | 420 | 2014 |
| Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis JZ Li, R Paredes, HJ Ribaudo, ES Svarovskaia, KJ Metzner, MJ Kozal, ... Jama 305 (13), 1327-1335, 2011 | 416 | 2011 |
| The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients JM Schapiro, MA Winters, F Stewart, B Efron, J Norris, MJ Kozal, ... Annals of Internal Medicine 124 (12), 1039-1050, 1996 | 352 | 1996 |
| Combination Therapy with Zidovudine and Didanosine Selects for Drug-Resistant Human Immunodeficiency Virus Type 1 Strains with Unique Patterns of pol Gene … RW Shafer, MJ Kozal, MA Winters, AKN Iversen, DA Katzenstein, ... Journal of Infectious Diseases 169 (4), 722-729, 1994 | 237 | 1994 |
| Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam T Le, M Wolbers, NH Chi, VM Quang, NT Chinh, NP Huong Lan, PS Lam, ... Clinical Infectious Diseases 52 (7), 945-952, 2011 | 232 | 2011 |
| Prevalence of antiretroviral drug resistance mutations in chronically HIV–infected, treatment-naive patients: implications for routine resistance screening before initiation of … RM Novak, L Chen, RD MacArthur, JD Baxter, KH Hullsiek, G Peng, ... Clinical infectious diseases 40 (3), 468-474, 2005 | 189 | 2005 |
| Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use T Le, J Chiarella, BB Simen, B Hanczaruk, M Egholm, ML Landry, ... PloS one 4 (6), e6079, 2009 | 171 | 2009 |
| Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance M Lataillade, J Chiarella, MJ Kozal Antiviral therapy 12 (4), 563-570, 2007 | 169 | 2007 |
| A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the … RD MacArthur, RM Novak, G Peng, L Chen, Y Xiang, KH Hullsiek, ... The Lancet 368 (9553), 2125-2135, 2006 | 169 | 2006 |
| Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial SMART Study Group* Annals of internal medicine 149 (5), 289-299, 2008 | 167 | 2008 |
| Fostemsavir in adults with multidrug-resistant HIV-1 infection M Kozal, J Aberg, G Pialoux, P Cahn, M Thompson, JM Molina, ... New England Journal of Medicine 382 (13), 1232-1243, 2020 | 154 | 2020 |
| Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies RS Braithwaite, MJ Kozal, CCH Chang, MS Roberts, SL Fultz, MB Goetz, ... Aids 21 (12), 1579-1589, 2007 | 154 | 2007 |
| A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients MJ Kozal, RW Shafer, MA Winters, DA Katzenstein, TC Merigan Journal of Infectious Diseases 167 (3), 526-532, 1993 | 154 | 1993 |
| Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naive subjects in the CASTLE study M Lataillade, J Chiarella, R Yang, S Schnittman, V Wirtz, J Uy, D Seekins, ... PloS one 5 (6), e10952, 2010 | 152 | 2010 |
| A nucleoside-and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naive HIV-infected patients: SPARTAN study results MJ Kozal, S Lupo, E DeJesus, JM Molina, C McDonald, F Raffi, ... HIV clinical trials 13 (3), 119-130, 2012 | 131 | 2012 |
| The hunt for HIV-1 integrase inhibitors M Lataillade, MJ Kozal AIDS Patient Care & STDs 20 (7), 489-501, 2006 | 112 | 2006 |
| Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy MJ Kozal, K Kroodsma, MA Winters, RW Shafer, B Efron, DA Katzenstein, ... Annals of internal medicine 121 (4), 263-268, 1994 | 103 | 1994 |
